Insiders · CTSO

CTSO insider transactions

Cytosorbents Corporation (CTSO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for CTSO

• 199d
  Chief Executive Officer Chan Phillip P. was granted 100,000 shares, increasing direct ownership by 7% to 1,482,963 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 303d
  Chief Executive Officer Chan Phillip P. was granted 105,600 shares, increasing direct ownership by 8% to 1,382,963 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 303d
  SEC Form 4 filed by Director Jones Edward Raymond

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 303d
  SEC Form 4 filed by Director Bator Michael G.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 303d
  Chief Financial Officer Mariani Peter J was granted 71,500 shares, increasing direct ownership by 15% to 538,113 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 303d
  SEC Form 4 filed by Director Kim Jiny

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 303d
  President and COO Capponi Vincent was granted 89,100 shares, increasing direct ownership by 13% to 766,268 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 303d
  Chief Medical Officer Deliargyris Efthymios was granted 70,000 shares, increasing direct ownership by 17% to 473,025 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 303d
  SEC Form 4 filed by Director Sobel Alan D.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 460d
  Director Bator Michael G. increased direct ownership by 7% to 151,273 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 466d
  President and COO Capponi Vincent increased direct ownership by 2% to 677,168 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 466d
  Chief Financial Officer Mariani Peter J increased direct ownership by 8% to 466,613 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 466d
  Chief Executive Officer Chan Phillip P. increased direct ownership by 3% to 1,277,363 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 466d
  Director Sobel Alan D. increased direct ownership by 18% to 145,757 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 501d
  Director Bator Michael G. exercised 15,879 in-the-money shares at a strike of $1.00, increasing direct ownership by 13% to 141,273 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 501d
  President and COO Capponi Vincent exercised 31,760 in-the-money shares at a strike of $1.00, increasing direct ownership by 5% to 665,168 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 501d
  Chief Medical Officer Deliargyris Efthymios exercised 16,233 in-the-money shares at a strike of $1.00, increasing direct ownership by 4% to 403,025 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 501d
  Director Sobel Alan D. exercised 21,950 in-the-money shares at a strike of $1.00, increasing direct ownership by 22% to 123,807 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 501d
  Chief Executive Officer Chan Phillip P. exercised 90,832 in-the-money shares at a strike of $1.00, increasing direct ownership by 8% to 1,243,195 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 501d
  Chief Financial Officer Mariani Peter J exercised 32,625 in-the-money shares at a strike of $1.00, increasing direct ownership by 8% to 433,988 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 539d
  Chief Financial Officer Mariani Peter J bought $19,294 worth of shares (20,000 units at $0.96), increasing direct ownership by 5% to 401,363 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 542d
  Chief Financial Officer Mariani Peter J bought $27,975 worth of shares (31,363 units at $0.89), increasing direct ownership by 9% to 381,363 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 607d
  SEC Form 4 filed by Chief Medical Officer Deliargyris Efthymios

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 607d
  SEC Form 4 filed by President and COO Capponi Vincent

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 660d
  Chief Financial Officer Mariani Peter J was granted 350,000 shares (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 660d
  SEC Form 3 filed by new insider Mariani Peter J

  3 - Cytosorbents Corp (0001175151) (Issuer)
• 794d
  Deliargyris Efthymios was granted 61,000 shares, increasing direct ownership by 18% to 409,433 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 794d
  SEC Form 4 filed by Jones Edward Raymond

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 794d
  SEC Form 4 filed by Sobel Alan D.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 794d
  Bloch Kathleen P. was granted 65,000 shares, increasing direct ownership by 14% to 532,941 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 794d
  SEC Form 4 filed by Bator Michael G.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 794d
  Capponi Vincent was granted 81,000 shares, increasing direct ownership by 14% to 665,134 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 794d
  SEC Form 4 filed by Kim Jiny

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 794d
  Chan Phillip P. was granted 96,000 shares, increasing direct ownership by 9% to 1,164,704 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 796d
  SEC Form 4 filed by Deliargyris Efthymios

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 796d
  SEC Form 4 filed by Capponi Vincent

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 796d
  SEC Form 4 filed by Bloch Kathleen P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 796d
  SEC Form 4 filed by Chan Phillip P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 905d
  Sobel Alan D. bought $30,001 worth of shares (22,557 units at $1.33), increasing direct ownership by 28% to 101,857 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 905d
  Capponi Vincent bought $25,000 worth of shares (18,797 units at $1.33), increasing direct ownership by 3% to 584,134 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 905d
  Deliargyris Efthymios bought $30,001 worth of shares (22,557 units at $1.33), increasing direct ownership by 7% to 348,433 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 905d
  Bator Michael G. bought $50,000 worth of shares (37,594 units at $1.33), increasing direct ownership by 43% to 125,394 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 905d
  Jones Edward Raymond bought $10,000 worth of shares (7,519 units at $1.33), increasing direct ownership by 9% to 88,834 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 905d
  Bloch Kathleen P. bought $50,000 worth of shares (37,594 units at $1.33), increasing direct ownership by 9% to 467,941 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 905d
  Kim Jiny bought $10,000 worth of shares (7,519 units at $1.33), increasing direct ownership by 11% to 77,819 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 905d
  Chan Phillip P. bought $100,000 worth of shares (75,188 units at $1.33), increasing direct ownership by 8% to 1,068,704 units (SEC Form 4)

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 991d
  SEC Form 4: Bloch Kathleen P. was granted 45,000 shares, increasing direct ownership by 11% to 442,347 units

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1027d
  SEC Form 3: New insider D'Amico Alex claimed ownership of 210,000 shares

  3 - Cytosorbents Corp (0001175151) (Issuer)
• 1034d
  SEC Form 4: Bator Michael G. bought $9,580 worth of shares (3,000 units at $3.19), increasing direct ownership by 4% to 87,800 units

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1062d
  SEC Form 4 filed by Bloch Kathleen P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1062d
  SEC Form 4 filed by Chan Phillip P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1062d
  SEC Form 4 filed by Sobel Alan D.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1062d
  SEC Form 4 filed by Bator Michael G.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1062d
  SEC Form 4 filed by Jones Edward Raymond

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1062d
  SEC Form 4 filed by Kim Jiny

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1062d
  SEC Form 4 filed by Capponi Vincent

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1062d
  SEC Form 4 filed by Deliargyris Efthymios

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1105d
  SEC Form 4 filed by Bloch Kathleen P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1123d
  SEC Form 4 filed by Bloch Kathleen P.

  4 - Cytosorbents Corp (0001175151) (Issuer)
• 1159d
  SEC Form 4 filed by Capponi Vincent

  4 - Cytosorbents Corp (0001175151) (Issuer)